All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-WFY2026 | Anti-MAVS (58N3B6) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | 58N3B6 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY2027 | Anti-MAVS (58N3E1) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | 58N3E1 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY2028 | Anti-MAVS (CBFYM-0173) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYM-0173 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY2029 | Anti-MAVS (CBFYM-1771) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYM-1771 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY2030 | Anti-MAVS (CBFYM-1772) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYM-1772 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY5279 | Anti-MAVS (58N3B6) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 58N3B6 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY5280 | Anti-MAVS (58N3E1) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 58N3E1 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY5281 | Anti-MAVS (CBFYM-0173) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYM-0173 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY5282 | Anti-MAVS (CBFYM-1771) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYM-1771 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY5283 | Anti-MAVS (CBFYM-1772) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYM-1772 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION